- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (68)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (236)
- Breast Cancer (712)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (158)
- Colon Cancer (166)
- Colorectal Cancer (106)
- Endocrine Tumor (4)
- Esophageal Cancer (40)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (2)
- Kidney Cancer (124)
- Leukemia (352)
- Liver Cancer (50)
- Lung Cancer (290)
- Lymphoma (286)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (102)
- Myelodysplastic Syndrome (64)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (102)
- Ovarian Cancer (176)
- Pancreatic Cancer (172)
- Parathyroid Disease (2)
- Penile Cancer (16)
- Pituitary Tumor (6)
- Prostate Cancer (148)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (294)
- Skull Base Tumors (54)
- Spinal Tumor (12)
- Stomach Cancer (58)
- Testicular Cancer (28)
- Throat Cancer (92)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (32)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (8)
- Biostatistics (2)
- Blood Donation (16)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (624)
- Complementary Integrative Medicine (22)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (220)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (116)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (870)
- Research (402)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (600)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (402)
- Survivorship (322)
- Symptoms (180)
- Treatment (1760)
Facing sinonasal undifferentiated carcinoma during pregnancy
BY Alyssa Warr
3 minute read | Published July 13, 2020
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on July 13, 2020
I was working as a physician assistant in California when my husband’s job moved us to Singapore. About a year after we got there, I started to experience pressure in my face, a watery eye, frequent sneezing and an occasional headache behind my right eye. I had these symptoms for two months before I decided to see a doctor. An ENT specialist scoped my nose, saw a mass and proceeded with a biopsy.
On Oct. 9, 2019, I was diagnosed with sinonasal undifferentiated carcinoma, a tumor that starts in the sinuses. My tumor had spread into the brain and was the size of a lime.
This was unexpected and unsettling news, but what made it even harder was that I was 18 weeks pregnant.
Keeping the baby and starting chemotherapy
Within a week, we returned home to California. Four days later, I was in an exam room with my OB/GYN when I had a seizure due to the swelling in my brain from the tumor.
After being rushed to the emergency room, I had another seizure. I was taken to the ICU, then admitted to the oncology unit. I decided to keep the pregnancy and started three rounds of chemotherapy during weeks 19 to 29 of my pregnancy. The tumor responded well to the chemotherapy, but I developed a cerebrospinal fluid leak due to a hole that the tumor left between my brain and sinuses.
Choosing proton therapy at MD Anderson
My doctor recommended that I go to MD Anderson for proton therapy. My first appointment was on Dec. 17, 2019. I met with head and neck oncologist Dr. Renata Ferrarotto, radiation oncologist Dr. Steven Frank and skull base tumor experts Dr. Franco DeMonte and Dr. Ehab Hanna. My husband and I decided to move to Houston in January 2020.
Dr. Ferrarotto spent a lot of time answering my questions with compassion. She was great at coordinating my care with my other physicians, including the OB/GYN who would deliver my baby. All of my doctors did a phenomenal job working together to care for me and my son.
A healthy baby, then proton therapy
My care team decided to not start my proton therapy until after the baby was born. I did a fourth round of chemotherapy to give the baby three more weeks to develop.
My son, Bennion (“Benny”), was born on Jan. 14, 2020, through a scheduled caesarean delivery. We scheduled the delivery at 31 weeks to give him a good chance of doing well while also ensuring we didn’t have to push back my proton therapy too much. After spending a few weeks in NICU, Benny had no identifiable issues.
I started proton therapy 10 days after I delivered Benny. Every time I saw Dr. Frank, he asked about our son. I felt very taken care of.
I completed my 35 proton therapy treatments on March 13, 2020, which happened to be my 28th birthday. Dr. Frank bought me a birthday cake to celebrate these two milestones.
Social distancing during the COVID-19 pandemic
Just as I finished proton therapy, COVID-19 began spreading in our area. We flew to Utah to be with our family, which was the scariest part. But we self-isolated and enjoyed the time with our newborn baby.
I received strength from my baby in utero. He is my first child, and I was motivated to go through treatment to be his mom.
As I learned, I can handle a lot more than I thought, thanks to the incredible people who love, care for and support me – including Benny, who doesn’t yet know how he gave me strength at a time when I needed it most.
Request an appointment at MD Anderson online or by calling 1-855-938-5278.
Related Cancerwise Stories

I felt very taken care of.
Alyssa Warr
Survivor